Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Sheng‐Teng Huang, Yeh Chen, Wei‐Chao Chang, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 826-826
Open Access | Times Cited: 25

Showing 25 citing articles:

Dissecting the Binding Affinity of Anti-SARS-CoV-2 Compounds to Human Transmembrane Protease, Serine 2: A Computational Study
Yongwei Shi, Jianxin Shen, Tao Yan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 587-587
Open Access
Predicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools
Brendo Araújo Gomes, Diégina Araújo Fernandes, Simony Carvalho Mendonça, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 633-633
Open Access
Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) cultivars using UPLC-MS/MS coupled to chemometric analysis, in vitro study and molecular docking
Reham S. Darwish, Alaa A. El‐Banna, Doaa A. Ghareeb, et al.
Journal of Ethnopharmacology (2022) Vol. 291, pp. 115038-115038
Open Access | Times Cited: 26
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Plant‐derived compounds as potential leads for new drug development targeting COVID‐19
Lingxiu Liu, Maxim V. Kapralov, Mark Ashton
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1522-1554
Open Access | Times Cited: 3
Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19
George Vere, Md Rashadul Alam, Sam Farrar, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 300-300
Open Access | Times Cited: 15
Renewable Hydrogen Production and Storage Via Enzymatic Interconversion of CO2 and Formate with Electrochemical Cofactor Regeneration
Eleftheria Sapountzaki, Ulrika Rova, Paul Christakopoulos, et al.
ChemSusChem (2023) Vol. 16, Iss. 17
Open Access | Times Cited: 8
Coffee as a dietary strategy to prevent SARS-CoV-2 infection
Chen-Shiou Wu, Yi‐Chuan Li, Shin‐Lei Peng, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Myrtucommulones and Related Acylphloroglucinols from Myrtaceae as a Promising Source of Multitarget SARS-CoV-2 Cycle Inhibitors
Simony Carvalho Mendonça, Brendo Araújo Gomes, Mariana Freire Campos, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 436-436
Open Access | Times Cited: 2
Tannic acids and proanthocyanidins in tea inhibit SARS-CoV-2 variants infection
Chung‐Yu Chen, Wei‐Jan Wang, Chen-Shiou Wu, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 5, pp. 2555-2569
Open Access | Times Cited: 2
Prospects of Coffee Leaf against SARS-CoV-2 Infection
Chen-Shiou Wu, Hsiu‐Mei Chiang, Yeh Chen, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4677-4689
Open Access | Times Cited: 14
Review from host and guest approach to new frontiers nutraceuticals in the era of COVID-19
Matteo Micucci, Silvia Gioacchini, Melissa Baggieri, et al.
Future Foods (2024) Vol. 9, pp. 100303-100303
Open Access | Times Cited: 1
Garcinia kola and garcinoic acid suppress SARS‐CoV‐2 spike glycoprotein S1‐induced hyper‐inflammation in human PBMCs through inhibition of NF‐κB activation
Olumayokun A. Olajide, Victoria U. Iwuanyanwu, Izabela Lepiarz‐Raba, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 12, pp. 6963-6973
Open Access | Times Cited: 13
Kampo Medicine Promotes Early Recovery From Coronavirus Disease 2019-Related Olfactory Dysfunction: A Retrospective Observational Study
Rie Ono, Ryutaro Arita, Shin Takayama, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection
Arianna Romani, Domenico Sergi, Enrico Zauli, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 3
Scutellarin and other metabolites as well as morphological and molecular characterization of the Scutellaria barbata lines from in vitro and in vivo cultivation
Justyna Lema-Rumińska, K. Sadowska, Alicja Tymoszuk, et al.
Industrial Crops and Products (2023) Vol. 195, pp. 116464-116464
Closed Access | Times Cited: 2
Identification of Flavonoids from Scutellaria barbata D. Don as Inhibitors of HIV-1 and Cathepsin L Proteases and Their Structure–Activity Relationships
Tingting Tang, Sumei Li, Bo‐Wen Pan, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4476-4476
Open Access | Times Cited: 2
A Tale of Two Proteases: MPro and TMPRSS2 as Targets for COVID-19 Therapies
Barbara Farkaš, Marco Minneci, Matas Misevicius, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 834-834
Open Access | Times Cited: 2
Enhanced expression and solubility of main protease (Mpro) of SARS-CoV-2 from E. coli
Rahul Ahuja, Anupamjeet Kaur, Geetika Kumari, et al.
Protein Expression and Purification (2023) Vol. 211, pp. 106337-106337
Closed Access | Times Cited: 2
Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2?
Igor José dos Santos Nascimento, Ricardo Olímpio de Moura
Medicinal Chemistry (2022) Vol. 19, Iss. 5, pp. 405-412
Closed Access | Times Cited: 4
Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula
Wei‐Jan Wang, Hsuan-Ting Tang, Shi‐Chen Ou, et al.
Cancer Letters (2024) Vol. 604, pp. 217198-217198
Closed Access
Biotechnological strategies for controlled accumulation of flavones in hairy root culture of Scutellaria lateriflora L.
Agata Wilczańska, Barbara Sparzak, Adam Kokotkiewicz, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report
Shuo-Wen Hung, Yuan-Ching Liao, I-Chang Chi, et al.
EXPLORE (2021) Vol. 19, Iss. 1, pp. 147-152
Open Access | Times Cited: 3
Comparative analysis of flavones from six commonly used <i>Scutellaria</i> species
Minmin Zheng, Yumin Fang, Qing Zhao
Medicinal Plant Biology (2023) Vol. 2, Iss. 1
Open Access
Could <em>Scutellaria barbata</em> D. Don be used for treating lung cancer and SARS-CoV-2?
Siukan Law, Albert Wingnang Leung, Chuanshan Xu
Infectious Diseases and Herbal Medicine (2021) Vol. 2, Iss. 1
Open Access
Page 1

Scroll to top